文献速递冠心病

生物可吸收支架与金属支架置入后动脉重塑比较

Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

ABSORB II随机试验中,383个病变(359例患者)在术后及3年随访时接受血管内超声检查,比较Absorb BVS与Xience金属药物洗脱支架置入后的血管重塑模式。结果显示BVS组平均血管面积相对变化显著大于DES组(6.7±12.6% vs 2.9±11.5%,p=0.003),平均管腔面积相对变化两组间亦有显著差异(1.4±19.1% vs -1.9±10.5%,p=0.031)。多因素分析表明BVS使用、女性、球囊-动脉比>1.25、扩张指数≥0.8、既往PCI及较高LDL-C水平是扩张性重塑的独立预测因素。

要点

  • BVS置入后3年血管扩张性重塑较金属DES更频繁且更显著。
  • BVS组管腔面积相对变化为正向,而DES组为负向。
  • BVS使用、女性、球囊-动脉比>1.25等是扩张性重塑独立预测因素。

核心结论

  • BVS置入后血管扩张性重塑比金属DES更频繁且更强烈,并可由患者基线特征和围术期因素决定。

研究设计与样本

  • ABSORB II随机对照试验中,383个病变(n=359例患者)在术后及3年随访时接受血管内超声检查,比较Absorb BVS与Xience金属DES置入后的血管重塑模式。

主要发现

  • BVS组平均血管面积相对变化显著大于DES组(6.7±12.6% vs 2.9±11.5%,p=0.003)。
  • BVS组与DES组平均管腔面积相对变化有显著差异(1.4±19.1% vs -1.9±10.5%,p=0.031)。
  • 多因素分析显示BVS使用、女性、球囊-动脉比>1.25、扩张指数≥0.8、既往PCI及较高LDL-C水平是扩张性重塑的独立预测因素。
  • 在BVS组中,术前坏死核心是扩张性重塑的独立决定因素。

关键数值与推荐

  • 以血管和管腔面积3年变化将血管重塑分为9种模式,均超出管腔和血管面积测量的可重复性范围。

临床怎么用

  • BVS置入后应关注血管扩张性重塑及其与患者基线特征和围术期因素的关系,以优化临床结局。

局限性

  • 观察到的管腔和血管重塑的临床效应尚需进一步大规模临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although previous observational studies have documented late luminal enlargement and expansive remodeling following implantation of a bioresorbable vascular scaffold (BVS), no comparison with metallic stents has been conducted in a randomized fashion. OBJECTIVES: This study sought to compare vessel remodeling patterns after either Absorb BVS or Xience metallic drug-eluting stent (DES) implantation (Abbott Vascular, Santa Clara, California) and determine the independent predictors of remodeling. METHODS: In the ABSORB II randomized trial, 383 lesions (n = 359) were investigated by intravenous ultrasound both post-procedure and at 3-year follow-up. According to vessel and lumen area changes over 3 years, we categorized 9 patterns of vessel remodeling that were beyond the reproducibility of lumen and vessel area measurements. RESULTS: The relative change in mean vessel area was significantly greater with the BVS compared to the DES (6.7 ± 12.6% vs. 2.9 ± 11.5%; p = 0.003); the relative change in mean lumen area was significantly different between the 2 arms (1.4 ± 19.1% vs. -1.9 ± 10.5%, respectively; p = 0.031). Multivariate analysis indicated that use of the BVS, female sex, balloon-artery ratio >1.25, expansion index ≥0.8, previous percutaneous coronary intervention, and higher level of low-density lipoprotein cholesterol were independent predictors of expansive remodeling. Furthermore, in the BVS arm, necrotic core pre-procedure was an independent determinant of expansive remodeling. CONCLUSIONS: Expansive vessel wall remodeling was more frequent and intense with the BVS than the metallic DES and could be determined by patient baseline characteristics and periprocedural factors. The clinical effect of the observed lumen and vessel remodeling must be investigated in further large clinical studies to optimize the clinical outcome of patients and lesions treated by bioresorbable scaffolds. (ABSORB II Randomized Controlled Trial; NCT01425281).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Serruys PW, Katagiri Y, Sotomi Y, et al. Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents. J Am Coll Cardiol. 2017. PMID: 28662808. doi:10.1016/j.jacc.2017.05.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。